In One Day, The New York Times Has Three News Pieces on Ivermectin. Is the Gray Lady Obsessed?

During the Covid pandemic there were many claims Ivermectin was a viable treatment for the coronavirus. The drug was originally developed for animals but was later touted as an anti-parasite wonder drug for humans. However, research found that in certain amounts Ivermectin kills SARS-CoV-2 the virus behind COVID-19 in a cell culture environment. In fact it was TrialSite that scooped ivermectin for both North America and Europe April 2020. This research was disputed by the medical mainstream which focused on a few studies which failed to show any benefits of Ivermectin.  But the evidence is actually conflicted. The mainstream medical establishment argues no benefit while research from several low and middle income countries suggests some benefit.  During the pandemic regulators and the medical establishment sought to discredit doctors recommending any use of Ivermectin off label with consenting patients. Now, it seems, The New York Times is obsessed with the drug.

Two Stories and a Video